Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
14
AMIX Quote, Financials, Valuation and Earnings
Last price:
$3.55
Seasonality move
:
--
Day range:
$3.38 - $3.57
52-week range:
$2.88 - $152.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.33x
Volume:
59.5K
Avg. volume:
159.6K
1-year change:
--
Market cap:
$4M
Revenue:
--
EPS (TTM):
-$13.96
Analysts' Opinion
-
Consensus RatingAutonomix Medical has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Autonomix Medical has an estimated upside of 700% from its current price of $3.50.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $3.50.
Fair Value
-
According to the consensus of 0 analysts, Autonomix Medical has 700% upside to fair value with a price target of -- per share.
AMIX vs. S&P 500
-
Over the past 5 trading days, Autonomix Medical has overperformed the S&P 500 by 10.27% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Autonomix Medical does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Autonomix Medical has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Autonomix Medical reported revenues of --.
Earnings Growth
-
Autonomix Medical has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Autonomix Medical reported earnings per share of -$2.47.
Enterprise value:
-36.7K
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
0.00x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -$3.3M | -$10.9M | -$1.3M | -$2.8M | |
| EBITDA | -- | -$8.1M | -$13.7M | -$6M | -$2.7M | |
| Diluted EPS | -- | -$7.68 | -$13.96 | -$5.72 | -$2.47 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | $5.4M | |
| Total Assets | -- | -- | -- | -- | $5.4M | |
| Current Liabilities | -- | -- | -- | -- | $1.3M | |
| Total Liabilities | -- | -- | -- | -- | $2.3M | |
| Total Equity | -- | -- | -- | -- | $3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -$8.3M | -$1.1M | -$1.6M | |
| Cash From Investing | -- | -- | -$24K | -- | -- | |
| Cash From Financing | -- | -- | $11.3M | $350K | -- | |
| Free Cash Flow | -- | -- | -$8.3M | -$1.1M | -$1.6M | |
AMIX
Sector
Market Cap
$4M
$45.6M
Price % of 52-Week High
2.3%
45.55%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
--
-31.35%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$3.25
200-day SMA
Sell
Level
$26.81
Bollinger Bands (100)
Sell
Level
6.87 - 14.79
Chaikin Money Flow
Sell
Level
-21.9M
20-day SMA
Sell
Level
$3.94
Relative Strength Index (RSI14)
Sell
Level
34.70
ADX Line
Sell
Level
25.58
Williams %R
Neutral
Level
-49.1803
50-day SMA
Sell
Level
$8.29
MACD (12, 26)
Sell
Level
-1.59
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Neutral
Level
34.3M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
--
Momentum Score
Level (--)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
Stock Forecast FAQ
In the current month, AMIX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AMIX average analyst price target in the past 3 months is --.
-
Where Will Autonomix Medical Stock Be In 1 Year?
According to analysts, the consensus estimate is that Autonomix Medical share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Autonomix Medical?
Analysts are divided on their view about Autonomix Medical share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Autonomix Medical is a Sell and believe this share price will drop from its current level to --.
-
What Is Autonomix Medical's Price Target?
The price target for Autonomix Medical over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AMIX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Autonomix Medical is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AMIX?
You can purchase shares of Autonomix Medical via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Autonomix Medical shares.
-
What Is The Autonomix Medical Share Price Today?
Autonomix Medical was last trading at $3.55 per share. This represents the most recent stock quote for Autonomix Medical. Yesterday, Autonomix Medical closed at $3.50 per share.
-
How To Buy Autonomix Medical Stock Online?
In order to purchase Autonomix Medical stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.27% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.76% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.62% over the past day.
